Implantable cardioverter defibrillator in high-risk long QT syndrome patients.
Viskin
Sami
S
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D002648:Child; D017147:Defibrillators, Implantable; D023381:Endpoint Determination; D005260:Female; D005500:Follow-Up Studies; D006323:Heart Arrest / Q000517:prevention & control; D006801:Humans; D008133:Long QT Syndrome / Q000401:mortality* / Q000628:therapy*; D008297:Male; D012189:Retrospective Studies; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D016019:Survival Analysis; D013575:Syncope / Q000517:prevention & control; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists